Archives for October 8, 2003

← 2003

Merck Bio launches proteomics tools

Merck Biosciences has introduced a new range of kits for removing and extracting protein from complex biological samples used in proteomic analysis.

Electroporation deal

Axon has licensed rights to Cellectricon's electroporation technology to enhance the performance of its Axoporator products, used to deliver DNA and other large molecules into cells.

Nucleic acids on tap

DRI and Tecan UK forge an alliance to use the former's CST reagents on Tecan's liquid-handling devices. The collaboration will provide automated nucleic acid purification systems.

Erweka launches dissolution tester

Germany's Erweka has introduced a new dissolution testing system that it says is more accurate and easy to use than rival products.

MG exits chemicals business

MG Technologies has decided to sell off its chemicals businessesand concentrate on process technology and components.

Price hike for propionates

Starting next year, Verdugt Bv of the Netherlands will increase the price it charges North American customers for calcium and sodium propionates.

Amersham soars on takeover bid

After Amersham confirmed yesterday that it had received a bid from an unnamed suitor wishing to buy the entire company, its shares rose more than 16 per cent; both J&J and Roche are in the rumour mill.

Alzheimer's diagnostic in the offing?

Scientists at Berlex Pharmaceuticals, the US subsidiary of Germany's Schering, have identified a biologic marker for Alzheimer's that could form the basis of a diagnostic test.

EU fines Aventis for price-fixing

Aventis has had its knuckles rapped by the European Union - and €99m fine - for its alleged involvement in a cartel to control the price of sorbates.